Here, we report the existence of an E2-induced NGB upregulation pathway for cell survival in both hepatoma (HepG2) and breast adenocarcinoma (MCF-7) cells, where the E2-pro-oncogenic signals prevail. Here, NGB is linked to hepatocellular carcinoma.